1. Home
  2. EIC vs SGMO Comparison

EIC vs SGMO Comparison

Compare EIC & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EIC
  • SGMO
  • Stock Information
  • Founded
  • EIC N/A
  • SGMO 1995
  • Country
  • EIC United States
  • SGMO United States
  • Employees
  • EIC N/A
  • SGMO N/A
  • Industry
  • EIC Finance/Investors Services
  • SGMO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EIC Finance
  • SGMO Health Care
  • Exchange
  • EIC Nasdaq
  • SGMO Nasdaq
  • Market Cap
  • EIC 287.1M
  • SGMO 242.0M
  • IPO Year
  • EIC 2019
  • SGMO 2000
  • Fundamental
  • Price
  • EIC $15.92
  • SGMO $1.07
  • Analyst Decision
  • EIC
  • SGMO Buy
  • Analyst Count
  • EIC 0
  • SGMO 6
  • Target Price
  • EIC N/A
  • SGMO $5.17
  • AVG Volume (30 Days)
  • EIC 116.0K
  • SGMO 3.8M
  • Earning Date
  • EIC 11-14-2023
  • SGMO 03-12-2025
  • Dividend Yield
  • EIC 13.63%
  • SGMO N/A
  • EPS Growth
  • EIC N/A
  • SGMO N/A
  • EPS
  • EIC 0.80
  • SGMO N/A
  • Revenue
  • EIC N/A
  • SGMO $52,291,000.00
  • Revenue This Year
  • EIC N/A
  • SGMO N/A
  • Revenue Next Year
  • EIC N/A
  • SGMO N/A
  • P/E Ratio
  • EIC $20.31
  • SGMO N/A
  • Revenue Growth
  • EIC N/A
  • SGMO N/A
  • 52 Week Low
  • EIC $13.00
  • SGMO $0.30
  • 52 Week High
  • EIC $16.48
  • SGMO $3.18
  • Technical
  • Relative Strength Index (RSI)
  • EIC 52.55
  • SGMO 37.60
  • Support Level
  • EIC $15.76
  • SGMO $1.07
  • Resistance Level
  • EIC $16.11
  • SGMO $1.24
  • Average True Range (ATR)
  • EIC 0.20
  • SGMO 0.09
  • MACD
  • EIC -0.01
  • SGMO 0.02
  • Stochastic Oscillator
  • EIC 50.00
  • SGMO 5.71

About EIC Eagle Point Income Company Inc.

Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: